Background
Our earlier studies have shown that, in some strains, resistance to Romet® is afforded by presence of a transferable R-plasmid (-55 kilobases) . Furthermore, we have demonstrated that R-plasmids from resistant strains ofE. ictaluri and A. salmonicida are very similar, if not identical, to each other as well as to R-plasmids from a previously described Escherichia coli 1898. The E. coli R-plasmids were from a 1986 equine cystitis case and were originally shown to be resistant to Tribrissen®, a potentiated sulfonamide (as is Romet®). Thus, three different bacterial species--each from different hosts and geographic origins--apparently possess the same molecular basis for resistance but do not share an obvious means for transfer among themselves. We believed that they may share a common source for their R-plasmid resistance.
Isolation of Antimicrobial Resistance Genes
In our study, we isolated the R-plasmid genes conferring resistance to Romet® from strains ofE. ictaluri, A. salmonicida, and E. coli using DNA primers constructed from sulfonamide resistance gene sequences sui I and sui II cataloged in GenBank (National Institutes of Health National Center for Biotechnology Information database). Homology of isolated genes was compared among the three species and to sui I and sui II by determining the DNA sequences and subsequently performing se'luence analysis comparisons.
Each bacterial strain (n = 10) was grown in 125 mL of Mueller Hinton Broth spiked with 30 mg Romet®/mL; incubation was for 48 h at 37°C for E. coli and 26°C for all other strains. A modified maxi prep protocol (Qiagen Inc., Chatsworth, California) was used for isolation ofR-plasmid DNA. Cells were centrifuged, the supernatant discarded, and 10 mL buffer PI (50 mM Tris, 10 mM EDTA, 100 mgRoase/mL, pH 8.0) was added to resuspend the cells. Ten mL ofbufferP2 (200 mMNaOH, 1% SDS) was added to lyse the cells and release DNA; after incubating 5 min, the reaction was stopped with 10 mL of buffer P3 (3M KC 2 H 3 0 2 , pH5.5). Samples were incubated on ice for 10 min, http://biology.usgs.gov/newsl98-012.htm 12/9/98 then centrifuged and 0.7 volumes ofisopropyl alcohol added to the supernatant to precipitate the DNA. Bacterial DNA from each isolate was used in polymerase chain reactions (PCR) with DNA primers constructed from sui I and sui II gene sequences. GenBank was searched for sulfonamide resistance gene sequences, yielding two consensus sequences, suI I and suI II. These sequences were imported into DNA sequence analysis software (pC Gene, IntelliGenetics, release 6.70), and suitable PCR primers were developed.
Gene sequences ofEnterobacteriaceae (Accession no. X12869) and E. coli (Accession no. X15024)
were used as a primer source for sui I, and plasmid pGS05 (Accession no. M36657) was used for sui II. Standard PCR reactions were done with 34 cycles, and resulting PCR products were subjected to electrophoresis in 1 % agarose gels at 66 V for 70 min. A 100-base pair DNA ladder served as a reference marker (Bayou Biolabs, Harahan, Louisiana). Positive PCR products (i.e., bands in the gel) that were suI I and sui II gene fragments were removed and purified using PCR purification columns (Qiagen).
DNA Sequence Determination
The PCR denaturation, annealing, and elongation cycle for the sequencing reactions was repeated 25 times. A standard control sequencing reaction (pGem) was used as a positive control. To end the sequencing program, the thermocycler was programmed to "soak" (4°C for infinite). Sequence mixtures were purified to remove excess dNTPs using Centrisep columns (Princeton Separations, Adelphia, New Jersey) and the DNA sequences determined using the ABI 310 Automated Sequencer (Applied Biosystems, Perkin Elmer, Foster City, California). Sequences obtained from the isolated resistance genes from our test strains were analyzed to obtain consensus sequences for both sui I and suI II. To determine homology, these sequences were compared to each other and to sequences from the GenBank Accession sequences using Sequence Navigator (Applied Biosystems, Perkin Elmer, Foster City, California).
Resistance Genes from Various Origins Shared Highly Conserved DNA Sequences
All Romet®-resistant strains yielded positive PCR products for both sui I and sui II, with the exception ofA. salmonicida strain MIl; this strain was indeed resistant to Romet® but lacked demonstrable sui I or sui II genes. In agarose gels, sui I gene PCR products were about 900 bp (basepairs) and sui II genes were approximately 400 bp. None of our test strains possessed only one of the genes--they had either both or none.
The suI I PCR fragments from our strains of A. salmonicida, E. ictaluri, and E. coli demonstrated 100% identity to each other. When a sui I consensus from these strains was further compared to the suI I GenBank sequence, they were calculated to be 99.8% homologous, differing at only one of the 603 bases sequenced. Similar results were obtained from evaluation of sui II genes. Sui II PCR products of our test strains showed a 95%-100% range in homology. When we compared our calculated suI II consensus sequence to that ofGenBank, a 97.5% homology resulted from different nucleotides at only 10 of 407 bases. The significance of these sequence similarities is that both suI genes are apparently conserved not only within one bacterial species, but also across different species and even across different hosts and geographic origins. We postulate that these two genes are being transferred via conjugation from R-factors (e.g., R-plasmid) present in environmental bacteria. With a source of an R-factor, along with use or perhaps overuse of an antimicrobial to create selection pressure, bacterial pathogens might readily acquire resistance, resulting in a situation where there is no option for therapy. .
